lobbying_activities: 2682339

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2682339	c87c8610-beb4-4dc3-b4d8-1bf23846edff	Q3	TIBER CREEK GROUP	20744	JAZZ PHARMACEUTICALS	2021	third_quarter	MED	Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2021-10-15T21:03:59.633000-04:00